Positives

• In intradermal microdialysis testing, patients given fentanyl showed only slight mast cell activation, with codeine and meperidine the only opioids producing meaningful tryptase and histamine release PubMed.
  
  
• Mast cell specialists list fentanyl as an acceptable perioperative opioid for MCAS patients, alongside remifentanil and buprenorphine, because of its low degranulation profile TMS Society.
  
  

Negatives

• Although rare, perioperative anaphylaxis to fentanyl has been reported in surgical patients, with anesthesia-related anaphylaxis carrying a 3.8 to 4.0% case-fatality rate when it does occur PMC.
  
  
• A patient experienced an intraoperative recurrence of a probable allergic reaction to remifentanil, illustrating that the synthetic opioid class is not entirely free of mast cell risk in MCAS patients ScienceDirect.
  
  

Hurdles & Side Effects

• MCAS patients undergoing surgery typically need a prearranged anesthesia plan with their mast cell specialist to ensure fentanyl is used in place of morphine or codeine and that pre-medication is in place TMS Society.
  
  
• Because fentanyl is restricted to inpatient or short-term medical settings, patients cannot rely on it for outpatient MCAS pain control and must transition to longer-acting alternatives like buprenorphine RTHM.